NO20064337L - Farmasoytisk middel inneholdende hyaluronan som en aktiv ingrediens - Google Patents

Farmasoytisk middel inneholdende hyaluronan som en aktiv ingrediens

Info

Publication number
NO20064337L
NO20064337L NO20064337A NO20064337A NO20064337L NO 20064337 L NO20064337 L NO 20064337L NO 20064337 A NO20064337 A NO 20064337A NO 20064337 A NO20064337 A NO 20064337A NO 20064337 L NO20064337 L NO 20064337L
Authority
NO
Norway
Prior art keywords
active ingredient
agent containing
pharmaceutical agent
containing hyaluronan
hyaluronan
Prior art date
Application number
NO20064337A
Other languages
English (en)
Inventor
Hiroko Yamanokuchi
Tadahiko Kato
Akira Asari
Original Assignee
Glycoscience Lab Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from JP2005277918A external-priority patent/JP2007084509A/ja
Priority claimed from JP2005297991A external-priority patent/JP2007106688A/ja
Priority claimed from JP2005348017A external-priority patent/JP2007153761A/ja
Application filed by Glycoscience Lab Inc filed Critical Glycoscience Lab Inc
Publication of NO20064337L publication Critical patent/NO20064337L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
    • A61K31/728—Hyaluronic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Dermatology (AREA)
  • Transplantation (AREA)
  • Epidemiology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)

Abstract

En farmasøytisk sammensetning inneholdende hyaluronan som en aktiv bestanddel er beskrevet. Et foretrukket hyaluronan er et tetrasakkarid (HA4) inneholdende 2 enheter, hvor en enkelt enhet er -D-glukuronsyre-(-1,3-D-N-acetylglukosamin-(-1,4-.
NO20064337A 2005-09-26 2006-09-25 Farmasoytisk middel inneholdende hyaluronan som en aktiv ingrediens NO20064337L (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2005277918A JP2007084509A (ja) 2005-09-26 2005-09-26 細胞賦活剤
JP2005297991A JP2007106688A (ja) 2005-10-12 2005-10-12 サイトカイン関連遺伝子及びケモカイン関連遺伝子の発現抑制剤
JP2005348017A JP2007153761A (ja) 2005-12-01 2005-12-01 シナプス伝達促進剤及びシナプス保護剤

Publications (1)

Publication Number Publication Date
NO20064337L true NO20064337L (no) 2007-03-27

Family

ID=37667620

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20064337A NO20064337L (no) 2005-09-26 2006-09-25 Farmasoytisk middel inneholdende hyaluronan som en aktiv ingrediens

Country Status (7)

Country Link
EP (1) EP1767211B1 (no)
AR (1) AR056091A1 (no)
AT (1) ATE552005T1 (no)
BR (1) BRMU8603015U (no)
CA (1) CA2560844C (no)
NO (1) NO20064337L (no)
RU (1) RU2342148C2 (no)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2008068854A1 (ja) 2006-12-05 2008-06-12 Glycoscience Laboratories, Inc. 変形性関節症の治療剤
JP5117110B2 (ja) * 2007-05-28 2013-01-09 生化学工業株式会社 Ｉ型アレルギー疾患治療剤
WO2013125634A1 (ja) * 2012-02-22 2013-08-29 株式会社ヒアルロン酸研究所 ヒアルロン酸フラグメントを有効成分とするサーチュイン誘導剤、組織修復剤、肝細胞増殖因子誘導剤、組織恒常性維持剤、及びｔｌｒ４作用剤
IT201600079773A1 (it) * 2016-07-29 2018-01-29 Matteo Bevilacqua Composizioni contenenti oligosaccaridi di acido ialuronico (HA4), condroitin solfato (CS2-4) ed eparan solfato (HS2-4), triterpeni pentaciclici e derivati per uso medico curativo e metodo per la preparazione di tali composizioni.
ES2974415T3 (es) * 2021-05-07 2024-06-27 Trb Chemedica Ag Acido hialurónico para prevenir o tratar la disfunción neurológica de nervios o células nerviosas

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0852501B1 (en) * 1995-09-28 2004-12-01 Sangstat Medical Corporation Use of hyaluronic acid as an immunosuppressant
JP4195107B2 (ja) * 1996-02-16 2008-12-10 生化学工業株式会社 ストレス蛋白質発現増強剤
IT1309588B1 (it) * 1999-03-05 2002-01-24 Altergon Sa Cerotto con spessore sottile contenente betametasone ed acidoialuronico per il trattamento di psoriasi, dermatite, dermatosi.
JP2003089647A (ja) * 1999-03-10 2003-03-28 Takada Seiyaku Kk 関節性疾患治療剤
CA2414211C (en) * 2000-07-07 2011-08-02 Seikagaku Corporation Hyaluronic acid oligosaccharide fractions and drugs containing the same
US6537968B1 (en) * 2000-07-24 2003-03-25 Alphamed Pharmaceuticals Corp Treatment of lupus erythematosus
US7060691B2 (en) * 2002-10-10 2006-06-13 Giuseppe Petrigni Pharmaceutical colloidal preparation useful in the treatment of respiratory diseases
US7511026B2 (en) * 2003-03-25 2009-03-31 Seikagaku Corporation Therapeutic agent for nerve damage
HUP0303779A2 (en) * 2003-11-20 2006-02-28 Richter Gedeon Vegyeszet Pharmaceutical compositions containing hyaluronan complex for the treatment of sclerosis multiplex
DE102004002001A1 (de) * 2004-01-14 2005-08-11 Reinmüller, Johannes, Dr.med. Mittel zur Behandlung von entzündlichen Erkrankungen

Also Published As

Publication number Publication date
ATE552005T1 (de) 2012-04-15
EP1767211B1 (en) 2012-04-04
CA2560844C (en) 2011-05-17
AR056091A1 (es) 2007-09-19
CA2560844A1 (en) 2007-03-26
EP1767211A1 (en) 2007-03-28
BRMU8603015U (pt) 2007-12-11
RU2342148C2 (ru) 2008-12-27
RU2006134169A (ru) 2008-03-27

Similar Documents

Publication Publication Date Title
MXPA06000013A (es) Agente terapeutico para sarcoma de tejido suave.
NO20091700L (no) Florizinanaloger som inhibitorer av glukose-ko-transporter 2
NO20075669L (no) Middel for a behandle ufrivillig bevegelse
EA200970081A1 (ru) Соединения, обладающие потенциирующим действием в отношении активности этионамида, и их применения
NO20073664L (no) Peptider med neuropeptid-2-reseptor (Y2R) agonist aktivitet
NO20090295L (no) Substituerte heteroarylderivater
NO20090175L (no) Stabile laquinimod sammensetninger
DOP2006000170A (es) Nuevos derivados de espirocromanona
NO20074872L (no) Pyrazoler
TW200638934A (en) Heteroaryl compounds as P2Y1 receptor inhibitors
NO20091395L (no) Nye tiofenderivater
NO20076252L (no) Oftalmiske anordninger for vedvarende levering av aktive forbindelser
DK1694318T3 (da) (S)-2-N-propylamino-5-hydroxytetralin som D3-agonistisk terapeutikum
ECSP088854A (es) Moduladores bencimidazolicos de vr1
NO20075111L (no) Farmasoytisk sammensetning
NO20082793L (no) Nye tiofenderivater
ATE472529T1 (de) Prolinamidderivate als natriumkanalmodulatoren
CY1112429T1 (el) Υποκατεστημενα παραγωγα σουλφοναμιδιου
NO341679B1 (no) Substituerte pyridylamidforbindelser, fremstilling av slike og farmasøytiske sammensetninger inneholdende slike, samt anvendelse som modulatorer av histamin H3-reseptoren
NO20055631L (no) Doseringsform inneholdende pantoprazol som aktiv ingrediens
NO20082445L (no) Neuropeptid-2 reseptor-agonister
BRPI0617655A2 (pt) composto ou um sal farmaceuticamente aceitável do mesmo, ou um isômero óptico do mesmo, uso de um composto, e, formulação farmacêutica
NO20081160L (no) Benzimidazoltiofen forbindelser
NO20092535L (no) Fumaratsalt av (alfa S, beta R)-6-brom-alfa-[2-(dimetylamino)etyl]-2-metoksy-alfa-1-naftalenyl-beta-fenyl-3-kinolinetanol
NO20090738L (no) Tilveiebringelse av EP2 agonister, fremgangsmate for fremstilling derav, farmasoytiske sammensetninger inneholdende disse forbindelser og fremgangsmater for anvendelse av forbindelsene og sammensetningene for a senke intraokkulaert trykk og behandle glaukom

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application